| Metric | FY 2025↕ |
|---|---|
| Revenue | — |
| Cost of Revenue | — |
| Gross Profit | — |
| R&D Expense | $0.0B |
| SG&A Expense | — |
| Operating Income | — |
| Net Income | $-0.0B |
| EPS (Basic) | $-0.16 |
| EPS (Diluted) | $-0.16 |
| Metric | FY 2025↕ |
|---|---|
| Total Assets | $0.0B |
| Current Assets | $0.0B |
| Cash & Equivalents | $0.0B |
| Total Liabilities | $0.0B |
| Current Liabilities | $0.0B |
| Stockholders' Equity | $0.0B |
| Metric | FY 2025↕ |
|---|---|
| Operating Cash Flow | $-0.0B |
| Investing Cash Flow | $-0.0B |
| Capital Expenditures | $0.0B |
| Financing Cash Flow | $0.0B |